Paola Rogliani

professore associato

Università degli Studi di Roma Tor Vergata Facoltà di Medicina e Chirurgia

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Paola Rogliani is an Associate Professor at Università degli Studi di Roma Tor Vergata, Facoltà di Medicina e Chirurgia, Italy. Her research focuses on chronic obstructive pulmonary disease (COPD) and asthma, with recent articles examining multi-criteria decision analysis in treatment strategies and novel drug discovery methods. She also investigates the clinical implications of biological therapies and the interactions between respiratory conditions and comorbidities such as type 2 diabetes mellitus.

Articles (30)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (7)

Girolamo Pelaia

Professor of Respiratory Medicine

Magna Graecia University

ITALY

View details

tommaso sciarra

Head of translational medicine

ITALY

View details

Mona Bafadhel

King’s College London

UNITED KINGDOM

View details

Gian Marco Manzetti

University of Rome Tor Vergata

ITALY

View details

fabiano di marco

University of Milan

ITALY

View details

Dejan Radovanovic

ITALY

View details

Clive Peter Page

King’s College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paola Rogliani

Research Interests

Explore related searches

Contact this professor

About

Articles (30)

Characterisation of the novel quinoline RCD405: Relaxant effects on cholinergic and histaminergic tone in human bronchi and small airways

Comparing major COPD triple therapy trials using a structured multi-criteria decision analysis: A deep dive into patient populations and outcomes

Is Shampooing Enough to Certify Hospital Dogs? Considering the Role of Owners and Trainers

Multi-Criteria Decision Analysis of Biologics in Chronic Obstructive Pulmonary Disease

Biologics for severe asthma: deciphering what is best for the patient

Triple extrafine fixed-dose combination in asthma: from randomized controlled trials to real-world evidence

The interplay between asthma and type 2 diabetes mellitus: mutual interactions and therapeutic implications

An update on long-acting muscarinic agents for asthma therapy

Novel drug discovery strategies for chronic obstructive pulmonary disease: the latest developments

Real-World Effectiveness of Triple Extrafine Fixed-Dose Combination with Beclomethasone/Formoterol/Glycopyrronium on Symptoms and Lung Function in COPD: A Systematic Review and Meta-Analysis

A clinician’s guide to single vs multiple inhaler therapy for COPD

Pulmonary Function Tests: Easy Interpretation in Three Steps

Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement

Understanding evidence from randomised controlled trials and meta-analyses: a comparative overview

Exacerbation Burden in COPD and Occurrence of Mortality in a Cohort of Italian Patients: Results of the Gulp Study

Use of human airway smooth muscle in vitro and ex vivo to investigate drugs for the treatment of chronic obstructive respiratory disorders

The Impact of Thermal Water in Asthma and COPD: A Systematic Review According to the PRISMA Statement

Exercise-Induced Asthma: Managing Respiratory Issues in Athletes

Investigational thymic stromal lymphopoietin inhibitors for the treatment of asthma: a systematic review

Clinical challenges in applying the new lung function test interpretive strategies: navigating pitfalls and possible solutions

Strategies for overcoming the biological barriers associated with the administration of inhaled monoclonal antibodies for lung diseases

An overview of the preclinical discovery and development of tezepelumab for the treatment of asthma

Can Treatable Traits Be the Approach to Addressing the Complexity and Heterogeneity of COPD?

Revisiting asthma pharmacotherapy: where do we stand and where do we want to go?

Delivering monoclonal antibodies via inhalation: a systematic review of clinical trials in asthma and COPD

Experimental drugs in clinical trials for COPD: artificial intelligence via machine learning approach to predict the successful advance from early-stage development to approval

Current and future developments in the pharmacology of asthma and COPD: ERS seminar, Naples 2022

Effects of SARS-CoV-2 on Pulmonary Function and Muscle Strength Testing in Military Subjects According to the Period of Infection: Cross-Sectional Study

Investigational anti IL-13 asthma treatments: a 2023 update

The impact of genomic variants on patient response to inhaled bronchodilators: a comprehensive update

Collaborators (7)

Girolamo Pelaia

tommaso sciarra

Mona Bafadhel

Gian Marco Manzetti

fabiano di marco

Dejan Radovanovic

Clive Peter Page

Make your next move.